This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Déjardin, J.
Right arrow Articles by Mougel, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Déjardin, J.
Right arrow Articles by Mougel, M.

 Previous Article  |  Next Article 

Journal of Virology, April 2000, p. 3709-3714, Vol. 74, No. 8
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

A Novel Subgenomic Murine Leukemia Virus RNA Transcript Results from Alternative Splicing

Jérôme Déjardin,1 Guillaume Bompard-Maréchal,1 Muriel Audit,1 Thomas J. Hope,2 Marc Sitbon,1 and Marylène Mougel1,*

Institut de Génétique Moléculaire de Montpellier, IFR 24, CNRS-UMR5535, and Université Montpellier II, F-34293 Montpellier Cedex 5, France,1 and Salk Institute for Biological Studies, La Jolla, California 920372

Received 4 October 1999/Accepted 26 January 2000

Here we show the existence of a novel subgenomic 4.4-kb RNA in cells infected with the prototypic replication-competent Friend or Moloney murine leukemia viruses (MuLV). This RNA derives by splicing from an alternative donor site (SD') within the capsid-coding region to the canonical envelope splice acceptor site. The position and the sequence of SD' was highly conserved among mammalian type C and D oncoviruses. Point mutations used to inactivate SD' without changing the capsid-coding ability affected viral RNA splicing and reduced viral replication in infected cells.


* Corresponding author. Mailing address: Institut de Génétique Moléculaire de Montpellier II (IGMM), IFR 24, CNRS-UMR5535, Université Montpellier II, 1919, Rte. de Mende, F-34293 Montpellier Cedex 5, France. Phone: 33 (4) 67 61 36 40. Fax: 33 (4) 67 04 02 31. E-mail: mougel{at}igm.cnrs-mop.fr.


Journal of Virology, April 2000, p. 3709-3714, Vol. 74, No. 8
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Yi, C.-r., Rosenberg, N. (2008). Mutations Affecting the MA Portion of the v-Abl Protein Reveal a Conserved Role of Gag in Abelson Murine Leukemia Virus (MLV) and Moloney MLV. J. Virol. 82: 5307-5315 [Abstract] [Full Text]  
  • Maurel, S., Houzet, L., Garcia, E. L., Telesnitsky, A., Mougel, M. (2007). Characterization of a natural heterodimer between MLV genomic RNA and the SD' retroelement generated by alternative splicing. RNA 13: 2266-2276 [Abstract] [Full Text]  
  • Swanson, I., Jude, B. A., Zhang, A. R., Pucker, A., Smith, Z. E., Golovkina, T. V. (2006). Sequences within the gag Gene of Mouse Mammary Tumor Virus Needed for Mammary Gland Cell Transformation.. J. Virol. 80: 3215-3224 [Abstract] [Full Text]  
  • Verhoef, K., Bilodeau, P. S., van Wamel, J. L. B., Kjems, J., Stoltzfus, C. M., Berkhout, B. (2001). Repair of a Rev-Minus Human Immunodeficiency Virus Type 1 Mutant by Activation of a Cryptic Splice Site. J. Virol. 75: 3495-3500 [Abstract] [Full Text]